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CHAPTER 1
Introduction
It is well known that the varying levels of metabolic requirements during exercise must
be followed by changes in cardiovascular dynamics in order to meet the metabolic needs of the
active skeletal muscle tissue. The cardiovascular system copes with an increase in metabolic
need by increasing blood flow to the working skeletal muscle through either increasing the
cardiac output of the heart, vascular resistance to the less metabolically demanding organs, or
varying levels of both. There are several mechanisms that control these changes and are seen as
feed forward and feed back in nature; though there are three main neural mechanisms known for
cardiovascular homeostasis during exercise. One is central command (32), which is a feed
forward mechanism; as well as the feedback mechanisms of the baroreceptor reflex (aka.
baroreflex) (66), and the skeletal muscle afferents, composed of both the mechano- and
metaboreflex (91; 109). For the purpose of this dissertation, the focus will be on the muscle
metaboreflex.
The muscle metaboreflex is a negative feedback blood flow and blood pressure raising
reflex. When blood flow to working muscles does not provide adequate oxygen and nutrients to
maintain the metabolic level for the activity, the working muscles create metabolic by-products,
also called metabolites. These metabolites stimulate group III and IV afferent nerve fibers (2; 6;
65; for review see 69). Activation of these afferent fibers elicits an increase in sympathetic tone.
Increased sympathetic tone to the heart and vasculature brings forth an increase in cardiac
output – known as the muscle metaboreflex.
Alam and Smirk (2) discovered the muscle metaboreflex serendipitously.

They

stumbled into this discovery after arresting circulation into and out of working muscles during a
bout of static exercise (multiple sets of experiments were done: seated calf raises, and hand grip
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exercises). They observed that during exercise, with the arrest of blood flow, there was a
significant increase in blood pressure. Moreover, instead of blood pressure returning to near
resting levels after the end of the exercise, blood pressure remained elevated while blood flow
to the formerly working muscles was still under arrest. This increase in blood pressure was
markedly greater than what was observed in similar experiments that did not include circulatory
arrest.
Since their discovery, the idea disappeared until 1964 when Asmussen and Nielsen (6)
used cycle ergometry and suggested that the reflexive nervous activity involved may be due to
activation of mechanical and/or chemical receptors in the working skeletal muscle. Coote et al
(19), furthered this idea by showing that, in cats, stimulation of skeletal muscle contraction
along with occlusion of the iliac artery produced a much greater pressor response as opposed to
stimulation alone.

In this study it was also discussed that the afferent signals sent from

metabolic receptors are likely transmitted through Group III and/or IV afferent fibers.
McCloskey et al, (65) confirmed that Group III and IV afferent nerves are involved with the
reflex; using two forms of nerve blockade to differentiate between large myelinated fibers
(group III) versus small unmyelinated fibers (group IV). Since then, it has been shown that
group IV afferent fibers are primarily chemo-sensitive, though possess some mechano-sensitive
properties (1), and that group III afferent fibers are primarily mechano-sensitive, but possess
some chemo-sensitive properties (1; 54). Following this, it has been determined that among the
stimuli that activate these afferents are: lack of oxygen delivery (98), lactate (101), hydrogen
ion concentration (H+), pH (99; 106), arachidonic acid (87), diprotonated phosphate (100), and
adenosine (63).
Normal mild exercise does not elicit a muscle metaboreflex pressor response.

As

mentioned previously, the muscle metaboreflex is activated by accumulation of metabolites in
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skeletal muscle (for review see 89). That is to say, one must either produce high levels of
metabolites, as during higher intensity exercise, or produce a reduction of flow to the working
muscles. When activated, the muscle metaboreflex causes, by increasing sympathetic activity,
an increase in cardiac output through an increase in both heart rate and cardiac contractility (79;
95). Depending on the intensity of the exercise, there is also a degree of vasoconstriction to
maintain proper blood pressure levels and thus an increase in central blood mobilization (97). It
appears these processes all occur in order to increase blood pressure and flow to ischemic
muscles. A study by Joyner (45) done in humans, and another by Mittelstadt et al. (70) have
shown that even the vasculature of the working skeletal muscle is under vasoconstriction during
exercise and muscle metaboreflex activation. These are the typical components of muscle
metaboreflex activation, in mild to moderate exercise, but the manifestation of muscle
metaboreflex activation can change in different circumstances.
What is observed during muscle metaboreflex activation in mild and moderate intensity
exercise is somewhat different than what is seen during severe exercise. Augustyniak et al (8),
performed a study using conscious dogs, and activated the muscle metaboreflex via partial
reduction of blood flow at the terminal aorta. In that study they observed that while at mild and
moderate levels of exercise, cardiac output increased significantly during muscle metaboreflex
activation; yet there was no significant increase in cardiac output at severe exercise during
muscle metaboreflex activation, though the pressor response still occurred. This shows an
alteration in the mechanism of muscle metaboreflex activation, shifting the main manifestation
of the muscle metaboreflex to be vasoconstriction rather than cardiac output. This allows for
blood pressure to increase considerably, without a considerable increase in cardiac output.
Joyner (45), suggests that this vasoconstriction may even impair flow to the muscles.
Heart failure is defined as a condition resulting from a myocardial dysfunction. This
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abnormality causes a decrease in cardiac output, resulting in the inability of the heart to
circulate enough oxygen rich blood throughout the body, to supply its metabolic needs.
Therefore, one of the typical signs is a decreased cardiac output. Another sign is increased level
of sympathetic activity (epinephrine and norepinephrine) in resting and exercise conditions.
The increased sympathetic activity also results in high tachycardia, and a reduced tolerance to
exercise (29; reviewed in 84).
A study conducted by Hammond et al (39), found that when dogs were in heart failure,
muscle metaboreflex activation during exercise could not elicit a significant increase in cardiac
output, leaving the pressor response entirely due to vasoconstriction. This effect of heart failure
on muscle metaboreflex during exercise is very similar to what is observed during severe levels
of exercise intensity, in normal conditions. Also found in heart failure dogs were increased
levels of: vasopressin, norepinephrine, and renin. A study by O’Leary et al (81), found similar
results, and also showed that the reason for a lack of a cardiac output increase was due to a
significant decrease in stroke volume, (heart rate was higher in heart failure when compared to
normal conditions). Ansorge et al (3), found similar results, as well as a decrease in the rate of
ventricular contraction, measured with dL/dt (change in myocardial segment length with respect
to time). It was also suggested that the increased sympathetic activity to the heart causes
significant vasoconstriction of the coronary arteries, which may limit the heart’s work capacity.
Sala-Mercado et al (94), used the pressure volume relationship to illustrate a reduced ventricular
contractility in dogs with heart failure while in exercise and muscle metaboreflex activation, as
compared to when they were normal. More specifically, they showed that during heart failure,
activation of the muscle metaboreflex did not further increase ventricular contractility when
compared to exercise without activation of the muscle metaboreflex.
Examples of previously conventional measures of cardiac performance are: stroke
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volume, ejection fraction, and maximal change of pressure (dP/dtmax), as well as maximal
myocardial segment length shortening (dL/dtmax), with respect to time. While these measures
are sensitive to contractile state, they are also influenced by changes in preload or afterload (48;
58), this is a major limitation in such techniques in measuring contractility. In order to take
changes in preload and afterload into account, indexes using the pressure-volume relationship
are used, preload recruitable stroke work (PRSW). The concept of preload recruitable stroke
work is a modification of the Frank-Starling relationship, with the use of end diastolic volume
instead of end diastolic pressure (30). Preload recruitable stroke work is a relationship of the
stroke work with respect to the end diastolic volume. Stroke work is a product of stroke volume
and the pressure change in the left ventricle throughout a cardiac cycle, i.e. the integral of the
pressure-volume relationship during one cardiac cycle. When stroke work is plotted as a
function of end diastolic volume, the slope of the resultant linear relationship is preload
recruitable stroke work, which is measured in the mmHg.ml/ml also measured as erg.103/cm3
(30).

Preload recruitable stroke work however, is both insensitive to changes in loading

conditions, and is not influenced by changes in ventricular size and structure (47).
Normally the muscle metaboreflex elicits an increase in cardiac performance (79). This
in itself would increase cardiac output; and if there were no changes in the vascular dynamics,
this would lead to a decrease in venous pressure, and subsequently a decrease in cardiac output.
In order to maintain preload the muscle metaboreflex also elicits vaso and venocostriction to
maintain right atrial pressure, coupled with the increase in cardiac output (97). But, this
vasoconstriction may include vasoconstriction of the coronary vasculature. Gwirtz et al. (37)
found that the increased -adrenergic activation, from increased sympathetic tone, as a result of
exercise, caused vasoconstriction in the coronary arteries. As well, it was suggested that this
coronary vasoconstriction might modulate cardiac function. This was shown by a significant
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vasodilation in the coronary vasculature, during exercise, following -receptor blockade.
Gwirtz, et al., not only showed an increase in blood flow, but also showed an increase in
cardiovascular performance with -blockade. O’Leary and Augustyniak (79) showed that
increased sympathetic activation elicited by the muscle metaboreflex served to maintain or even
increase stroke volume during tachycardia in exercise. The question remained as to whether the
muscle metaboreflex would affect coronary blood flow. Following this, Ansorge et al. (4),
discovered that during severe exercise, activation of the muscle metaboreflex significantly
reduced the coronary vascular conductance. Furthermore, with dogs in heart failure, Ansorge et
al. (3), found that this reduction in coronary vascular conductance was not only seen in
moderate levels of exercise, but also mild levels of exercise, with activation of muscle
metaboreflex. Sala-Mercado et al. (94), used the pressure-volume relationship to illustrate a
reduced ventricular contractility in dogs with heart failure while in exercise and muscle
metaboreflex activation, when compared to the control condition. During heart failure, it is
known that there is a markedly high level of sympathetic activity; however no significant
increases in cardiac output are observed during rest, mild, moderate or severe exercise
conditions when compared to normal conditions with their corresponding intensities (39; 40).
In fact, cardiac output is lower.
It is possible that one reason for this inability to increase cardiac output would be
coronary vasoconstriction. O’Leary et al. (82) illustrated a significant increase in coronary
vascular conductance after muscle metaboreflex activation in normal dogs during -adrenergic
blockade.

In this study, a higher increase in cardiac output during muscle metaboreflex

activation while under -adrenergic blockade was also observed. Cardiac myocytes are able to
increase their oxygen uptake up to five times during exercise. However, as depicted in Figure
1.1, even when the body is at rest the heart muscle extracts ~75% of the oxygen in arterial blood,
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while the rest of the body (mostly skeletal muscle) extracts ~25%. As workload intensity
increases, skeletal muscle is able to extract more oxygen from the blood. Since the heart muscle
already extracts a large amount of oxygen when the body is at rest, it is unable to extract
substantially more oxygen when workload increases. This leaves increasing coronary blood
flow as the primary mechanism of delivering more oxygen to the cardiac myocytes (reviewed in
10; 105). In normal conditions, metabolic vasodilation facilitates an increase in coronary blood
flow during heavy cardiac oxygen demand or ischemic situations.

Factors that stimulate

coronary vasodilation are adenosine, potassium channels, nitric oxide (reviewed in 105), low
myocardial oxygen tension, or high myocardial carbon dioxide tension (11). The reduction in
coronary vascular conductance during muscle metaboreflex activation suggests that the
vasoconstriction caused by increased sympathetic tone, elicited by the muscle metaboreflex, is
more powerful than the vasodilatory effects of the metabolic factors released with increase in
cardiac work (eg. increased cardiac output).

This vasoconstriction may limit coronary

metabolic vasodilation, and could suppress increases in left ventricular performance: though this
phenomenon has yet to be determined.
Myocardial vs. Skeletal Muscle O2 Extraction

O2 Concentration (mL %)

25
20
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Figure 1.1. Illustration of cardiac muscle and somatic oxygen extraction, from arterial blood.
The descending aorta contains oxygen rich blood. The pulmonary artery blood contains
deoxygenated blood from throughout the body, while the coronary sinus contains deoxygenated
blood specifically from the heart. (Adapted from 47; 75)
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The purpose of this study was to determine if, during mild, dynamic exercise (2mph
10% grade), the 1-adrenergic mediated vasoconstriction that occurs with muscle metaboreflex
activation, results in a suppressed left ventricular contractility in normal and heart failure
conditions. I hypothesized that:
1 – The muscle metaboreflex- induced increases in cardiac sympathetic activity functionally
vasoconstricts the coronary vasculature and this limitation in raising coronary blood flow
acts to limit the ability to raise ventricular contractility and therefore cardiac output in the
normal animal.
2 – In animals with heart failure, the inability to raise ventricular contractility and cardiac output
with metaboreflex activation is not simply due to the ventricular dysfunction, but is also
attributable to this coronary vasoconstriction.
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CHAPTER 2
Muscle Metaboreflex-Induced Coronary Vasoconstriction Functionally Limits Increases
in Ventricular Contractility
Abstract
Muscle metaboreflex activation during dynamic exercise induces a substantial increase
in cardiac work and oxygen demand via a significant increase in heart rate, ventricular
contractility and afterload. This increase in cardiac work should cause coronary metabolic
vasodilation. However, little if any coronary vasodilation is observed due to concomitant
sympathetically induced coronary vasoconstriction. The purpose of the present study is to
determine whether the restraint of coronary vasodilation functionally limits increases in left
ventricular (LV) contractility.

Using chronically instrumented, conscious dogs (n=9) we

measured arterial pressure (MAP), cardiac output (CO), circumflex blood flow (CBF), and
calculated coronary vascular conductance (CVC), maximal derivative of ventricular pressure
(dp/dt), and preload recruitable stroke work (PRSW) at rest and during mild exercise (2mph)
before and during activation of the muscle metaboreflex. Experiments were repeated after
systemic alpha-1 adrenergic blockade (prazosin ~50 g/kg). During prazosin we observed
significantly greater increases in CVC (0.64 ±0.06 vs. 0.46 ±0.03 ml/min/mmHg, p<0.05), CBF
(77.9 ±6.6 mL/min vs. 63.0 ±4.5 mL/min, p<0.05), CO (7.38 ±0.52 L/min vs. 6.02 ±0.42 L/min,
p<0.05), dP/dtmax (5449 ±339 mmHg/s vs 3888 ±243 mmHg/s, p<0.05), and PRSW (160.1
±10.3 erg·103/mL vs. 183.8 ±9.2 erg·103/mL, p<0.05), with metaboreflex activation vs. those
seen in control experiments.

We conclude that the sympathetic restraint of coronary

vasodilation functionally limits further reflex increases in LV contractility.
Introduction
During exercise when oxygen demand by the active skeletal muscle is greater than
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oxygen supply, metabolites accumulate stimulating chemosensitive afferents (62; 87; 98-100;
106) eliciting a pressor response termed the muscle metaboreflex (2; 6; 98). In contrast to other
cardiovascular reflexes which raise arterial pressure primarily via peripheral vasoconstriction
(e.g. the arterial and cardiopulmonary baroreflexes (17; 44; 85)), during submaximal exercise
involving a large muscle mass the muscle metaboreflex-induced pressor response occurs
virtually solely via increases in cardiac output (8; 39; 109). Raising the total flow available for
perfusion is the only effective strategy to substantively increase skeletal muscle blood flow
during exercise because the vast majority of cardiac output is already directed to this vascular
bed (90). Vasoconstriction of inactive vascular beds has little potential to improve skeletal
muscle blood flow in this setting (78). Thus, this reflex has been described as a flow-sensitive,
flow-raising reflex (8; 88; 98). Muscle metaboreflex activation increases cardiac output (CO)
by raising heart rate (HR) and ventricular contractility (22; 95). Left ventricular preload is
sustained via substantial central blood volume mobilization (97) thereby allowing the
chronotropic and inotropic responses to maintain steady-state increases in cardiac output. This
substantial increase in cardiac work (large increases in cardiac output pumped against a much
higher arterial pressure) would be expected to elicit marked metabolic coronary vasodilation
(27; 49). Furthermore, the large increase in sympathetic activity could elicit significant 
mediated feed-forward vasodilation (33; 34). However, the reflex rise in sympathetic activity to
the heart may also activate vascular  adrenergic receptors (37). Previous studies from our
laboratory showed that despite the marked increase in cardiac work, no coronary vasodilation
occurred when the reflex was activated during submaximal dynamic exercise (4). The potent
vasoconstrictor impetus of this reflex was revealed when the marked increase in cardiac work
did not or could not occur. In these settings actual coronary vasoconstriction was observed with
metaboreflex activation (as seen in normal animals during severe exercise when cardiac output
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is already maximal (4; 8), also during mild exercise after beta adrenergic blockade with acute
ventricular pacing which causes acute ventricular dysfunction (4), as well as after induction of
chronic heart failure (3)). In contrast, when the metaboreflex was activated after blockade of
coronary vascular  adrenergic receptors, substantial coronary vasodilation occurred with the
large increases in cardiac work (82). Taken together, these studies support the concept that
increases in cardiac sympathetic nerve activity simultaneously engender both coronary
vasodilation (due to the substantial increase in cardiac work and possible  mediated feedforward vasodilation) as well as neurogenic vasoconstriction (via activation of coronary 
adrenergic receptors) with the resulting level of coronary vasomotor tone dependant on the level
of activation of each mechanism.
To what extent this functional metaboreflex-induced coronary vasoconstriction limits
the ability to improve ventricular function and therefore ultimately limits the ability to increase
cardiac output and improve oxygen delivery to the active muscle is unknown. Gwirtz et al, (37)
have shown that  adrenegic blockade accentuates the increase in coronary blood flow and left
ventricular performance (dP/dt and myocardial segment dL/dt) observed during moderate
exercise. These data indicate that even during moderate dynamic exercise the vasoconstrictor
effects of increases in cardiac sympathetic nerve activity limits increases in myocardial
performance. To what extent this change in segment performance translates into increases in
global cardiac function is unclear. Previous to this, Heyndrickx et al, (42) showed no increase
in left ventricular dP/dt during exercise after systemic infusion of prazosin. Notably Gwirtz et
al, (37) used intracoronary infusion of prazosin resulting in unaltered loading conditions which
may explain the different findings in dP/dt. O’Leary et al, (82) have shown that metaboreflex
activation after systemic  adrenergic blockade resulted in larger increases in CO. Whether the
higher CO was due to an increased cardiac contractility brought about by the greater coronary
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vasodilation vs. the lower left ventricular afterload caused by systemic vasodilation caused by
the  adrenergic blockade is unknown.
In the present study we tested whether this restraint of coronary vasodilation by the
metaboreflex-induced increase in cardiac sympathetic nerve activity functionally limits the
ability to increase left ventricular contractility. We assessed left ventricular contractility via
analysis of changes in the pressure-volume relationship. We hypothesized that blockade of 
adrenergic receptors would now allow coronary vasodilation during metaboreflex activation and
that the increase in coronary blood flow would further the reflex increase in left ventricular
contractility.
Methods
All of the methods and procedures were reviewed and approved by the Wayne State
University Institutional Animal Care and Use Committee. The experiments were conducted on
mongrel dogs (n=9), weighing 22.7 (± 2.02) kg. The dogs were selected for their willingness to
exercise on a motor-driven treadmill. Although no selection was made for gender, by random
availability of laboratory dogs, all animals were female. We have previously shown that gender
has little or no effect on metaboreflex responses in dogs (55).
The medications and surgical preparations used have been described in detail previously
(3; 4; 95). Briefly, a 20mm flow transducer was placed around the aortic root to assess cardiac
output. Hydraulic vascular occluders were placed on the superior and inferior vena cavae to
manipulate preload. Two pairs of sonomicrometry crystals were implanted in the endocardium
of the left ventricle, to measure the long axis and the short axis which were used to estimate
ventricular volume. A catheter was placed in the left ventricle and its telemeter-pressure
transducer was implanted subcutaneously for left ventricular pressure. A 3 mm flow transducer
was placed on the circumflex artery to assess coronary flow. Arterial and central venous
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catheters were placed to measure systemic blood pressures. In a retroperitoneal abdominal
approach, a vascular occluder was placed about the terminal aorta. Just proximal to this
occluder, a 10mm flow transducer was placed about the aorta to measure hindlimb blood flow
(HLBF). The animals were allowed at least 7 days for recovery prior to the experiments.
Experimental Protocol
Each dog was directed to stand on the treadmill for 10-15 minutes while all equipment
was connected and adequacy of the signals verified. All data were recorded on digital recording
systems.
We obtained 1 minute of steady-state resting data with the dog standing on the treadmill.
Steady-state data and data during transient vena caval occlusions (for variably loaded pressurevolume loops) were recorded during the conditions of: rest, mild exercise (3.2 km/h), and mild
exercise with muscle metaboreflex activation. The reflex was activated by partially inflating the
vascular occluder on the terminal aorta to reduce hindlimb blood flow to approximately 50% of
the normal value during mild exercise. The experiments were performed with and without 
blockade (prazosin; 20-50 g/kg, i.v. 30 minutes prior to exercise). In each experiment, the dose
of prazosin was sufficient to abolish any pressor response to 4 g/kg of phenylephrine for the
duration of the experiment.
Data Analysis
We calculated left ventricular volume using a modified ellipsoid equation: LVV =
(π/6)×(SA)2×(LA): where LVV is the left ventricle volume, SA (short axis) represents the
distance between the anterior and posterior crystals, and LA (long axis) represents the distance
between the crystals placed on the base and apex of the left ventricle (58). The pressure-volume
loops were plotted for each condition. Preload recruitable stroke work (PRSW), and ± dP/dt
were calculated. PRSW is the slope of the relationship between stroke work and the LV end

14
diastolic volume (illustrated in figure 2.1). An increased slope reflects an increased contractility,
as a decreased slope reflects a decrease in contractility (30; 47; 59). Cardiac power was
calculated as the product of stroke work and heart rate. The integral of the cardiac output wave
was calculated to give stroke volume. Coronary vascular conductance (CVC) was calculated as
CBF/(MAP-CVP): where CBF is coronary blood flow, MAP is mean arterial pressure, and CVP
is central venous pressure. Systemic vascular conductance to all non-ischemic areas (e.g. all
areas except the hindlimbs) is termed non-ischemic vascular conductance (NIVC) and was
calculated as (CO-HLBF)/ (MAP-CVP). A repeated measures factorial ANOVA, was used for
the main effects analyses, and a pair-wise comparison was used for post-hoc analyses using the
Test for Simple Effects. Statistical significance was defined as P < 0.05. Regression analyses
were conducted with CVC with respect to cardiac power for each animal, and the slopes were
compared between control and  blockade by repeated measures one way ANOVA.
Results
Table 2.1 shows the levels of HLBF at rest, during exercise and during metaboreflex
activation before and after  adrenergic blockade. Prazosin caused a small, but significant
increase in HLBF over control values during exercise. HLBF was reduced to the same values in
both conditions for activation of the muscle metaboreflex.
Figure 2.2 shows the mean steady state values of MAP, HR, left ventricular end diastolic
and end systolic volumes, CO, and NIVC, at rest, mild exercise, and during exercise with
metaboreflex activation in control and after 1 blockade. In control there was no change in
MAP or stroke volume (SV) from rest to mild exercise, however HR, CO, and NIVC were
increased. Imposed reductions in HLBF caused muscle metaboreflex-induced increases in
MAP, HR, SV and CO. No significant change in NIVC occurred with metaboreflex activation.
At rest, 1 blockade caused a significant decrease in MAP, marked tachycardia and reduced SV,
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due to a reduced end diastolic volume. Responses to mild exercise were similar to control with
the exception that now SV slightly increased. Metaboreflex activation caused a significant
though lesser increase in MAP, and a significant increase in SV. End diastolic volume was still
reduced compared to control, however end systolic volume was also reduced, resulting with a
comparable SV between control and 1 blockade. A greater reflex increase in HR and CO as
compared to control and a significant increase in NIVC occurred. LV end systolic volume was
significantly different across workloads, but had no significant difference between conditions
(control vs. 1 blockade) and no significant interaction, so a pairwise comparison could not be
calculated.
Figure 2.3 shows left ventricular hemodynamic and inotropic responses to mild exercise
and metaboreflex activation before and after 1 blockade. In control there was a significant
increase from rest to mild exercise in CBF, CVC, dP/dtmax, and PRSW. Metaboreflex activation
increased coronary blood flow and left ventricular contractility, however no vasodilation
occurred in the coronary circulation as there was no significant increase in CVC, thus all of the
increase in CBF was due to the increase in perfusion pressure. Under 1 blockade there was
also a significant increase in all illustrated parameters from rest to mild exercise, which were
statistically greater in CVC and dP/dtmax compared to control. After 1 blockade, activation of
the muscle metaboreflex now elicited significantly greater increases in CBF. Although the rise
in perfusion pressure was smaller, substantial coronary vasodilation occurred. Metaboreflex
activation in this setting caused significantly greater increases in both indices of myocardial
contractility.
After  blockade the slope of the relationship between CVC and cardiac power (used as
an index of myocardial O2 consumption) was significantly increased. Further, this relationship
was extended over a significantly greater range as both CVC and cardiac power were
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significantly greater during muscle metaboreflex stimulation after  blockade (Figure 2.4).
Figure 2.5 shows the relationship between PRSW and CBF. There was no difference
between the slope of the relationship between control and after  blockade therefore the data
were combined into one regression. After  blockade, greater increases in CBF occurred with
metaboreflex activation which also elicited substantially greater increases in ventricular
contractility.
Table 2.1. Hind-limb blood flow at rest, during exercise and during metaboreflex activation
before and after α1 adrenergic blockade
HLBF (L/min)
Rest
Ex.
Ex.+MMA
Control

0.58±0.05

1.00±0.09 †

0.52±0.04

α1 blockade

0.61±0.06

1.07±0.09 * †

0.55±0.04

Levels of hindlimb blood flow at rest, during exercise (Ex) and during exercise with metaboreflex
activation (Ex+MMA) before and after  adrenergic blockade. During Ex+MMA, hindlimb blood
flow was mechanically reduced to the same values in both conditions. An * above a specific setting
signifies a significant pairwise comparison (P < 0.05). A † above a column signifies a significant
increase from rest to mild exercise (P < 0.05).
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Figure 2.1: Example of pressure-volume loop during preload reduction (A), illustrating stroke
work of a single loop (shaded) and the end diastolic volume point (●) for each loop. (B)
Example of how the end diastolic points and corresponding stroke work for weach loop is used
to illustrate preload recruitable stroke work and how it can be used to assess contractility.
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Figure
2.2:
Hemodynamic
responses: Mean arterial pressure
(MAP), heart rate (HR), Left
Ventricular Volumes (Left VVs),
cardiac output (CO), and nonischemic vascular conductance
(NIVC); during rest, mild exercise
(Ex), and mild exercise with
MMA (Ex+MMA); in control
(black bars) and 1 blockade
conditions (striped bars). All
parameters showed a significance
across workload settings, as well
as significance between control
and prazosin conditions (P <
0.05); with the exception of stroke
volume and LV end systolic
volume
(which
were
only
significant
across
workload
settings). All parameters had a
significant interaction between the
two independent variables, with
the exception of LV end systolic
volume. * (between two bars)
signifies a significant pairwise
comparison (P < 0.05). † above a
column signifies a significant
increase from the previous
workload. A ♣ above a specific
setting signifies a significant
pairwise comparison in left
ventricle stroke volume (P < 0.05).
A ‡ above a column signifies a
significant increase in LV end
diastolic volume from the previous
workload while a # above a
column indicates a significant
increase in stoke volume from the
previous workload (P < 0.05). An
* next to the bracket indicates a
significance between LV end
systolic volume across workloads
but not between control and 1
blockade conditions.
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Figure 2.3: Left ventricular
hemodynamic
and
function
responses: Coronary blood flow
(CBF),
coronary
vascular
conductance (CVC), maximal rate
of left ventricular pressure change
(dP/dtmax), and preload recruitable
stroke work (PRSW); during rest,
mild exercise (Ex), and mild
exercise with MMA (Ex+MMA); in
control (black bars) and 1 blockade
conditions (striped bars).
All
parameters showed a significance
across workload settings, as well as
significance between control and
prazosin conditions (P < 0.05). All
parameters had a significant
interaction between the two
independent variables. An * above
a specific setting signifies a
significant pairwise comparison (P
< 0.05). A † above a column
signifies a significant increase from
the previous workload (P < 0.05).
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Contractility
indicated
by
preload
recruitable
stroke
work
(PRSW) with respect to
coronary blood flow (CBF).
As no significant difference
between control and 1
blockade was found (P >
0.05), a single relationship is
represented by a single line.
The averaged values in
control are represented with
black circles (●) while
averaged values during 1
blockade are shown as open
circles (○).
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Figure 2.4:
Coronary
vascular conductance (CVC)
plotted as a function of
cardiac power. The broken
regression line represents the
average relationship between
CVC and cardiac power in
control while the solid
regression line represents the
corresponding
average
relationship
during
1
blockade.
The averaged
values
in
control
are
represented
with
black
diamonds (♦) while averaged
values during 1 blockade
are shown as open diamonds
(◊). The bracket shown to
the right with the * signifies
the significant difference
between the two slopes (P <
0.05).
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Discussion
This is the first study to show that during dynamic exercise the sympathetically-induced
restraint of coronary vasodilation during muscle metaboreflex activation impairs increases in
left ventricular contractility.

During metaboreflex activation a “push-pull” situation likely

exists as a result of the increase in sympathetic activity to the heart. The increase in metabolic
vasodilation coupled with possible vascular β-mediated feed forward vasodilation is opposed by
direct α-mediated vasoconstriction. The direct vasoconstrictor drive limits vasodilation and the
restrained increase in blood flow limits increases in ventricular performance. Suppressing the
increase in ventricular contractility likely limits the ability to raise cardiac output and thereby
functionally limits the ability of the muscle metaboreflex to improve blood flow to the active
skeletal muscles.
Coronary perfusion/dilation and ventricular performance: cause and effect:
The complex relationship between coronary perfusion and ventricular performance can
make it difficult to discern the difference between cause and effect. Changes in flow can elicit
changes in function and changes in function can elicit metabolic coronary vasodilation. Since
flow will vary with changes in both vessel caliber and perfusion pressure, vasodilation can only
be assessed via changes in conductance (or resistance, we prefer conductance (78)). Ventricular
function is likely limited by blood flow (or O2 delivery (77)) rather than vasodilation per se (e.g.
flow can change solely due to changes in perfusion pressure (3; 4)). We addressed this in two
distinct ways. Figure 2.4 shows that the relationship between cardiac power and coronary
vascular conductance was shifted upwards with a significantly steeper slope after 1 adrenergic
blockade. This shows that with metaboreflex activation greater vasodilation occurs after 1
adrenergic blockade at any level of metabolic stimuli for vasodilation (as indexed by cardiac
power). We based this analysis on that done by Huang and Feigl (43), who showed that the
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relationship between coronary blood flow and myocardial O2 consumption is linear but that the
slope of the relationship during exercise increases after regional 1 receptor blockade. In that
study (43), perfusion pressure was not different with coronary  receptor blockade therefore
changes in blood flow will be proportionally equivalent to changes in conductance and therefore
flow is a valid index of vasodilation/vasoconstriction. In our study, perfusion pressure was
different both before and after 1 receptor blockade and markedly so between exercise and
metaboreflex activation therefore differences in vasomotor tone must be addressed via changes
in conductance (78). For example, in the control experiments large increases in coronary blood
flow occurred with metaboreflex activation yet this was not due to vasodilation inasmuch as
conductance remained unchanged. All of the increase in flow was due to an increase in
perfusion pressure.
Whether due to increased perfusion pressure or vasodilation, increases in blood flow
may allow increases in ventricular function by providing more O2 delivery (77). O2 extraction
in the coronary circulation is already near maximal under basal conditions, therefore increases
in myocardial O2 consumption with exercise occur predominately via increases in coronary
blood flow (49). In addition, mild exercise and metaboreflex activation in this model elicit
minimal increases in arterial O2 content (~ 5%) (80) therefore increases in O2 delivery occur via
increases in blood flow.

We found that the relationship between ventricular contractility

(PRSW) and blood flow was exceedingly linear. 1 adrenergic blockade only extended the
range of this relationship and did not affect the slope. With metaboreflex activation in the
control experiments, all of the increase in coronary blood flow and therefore O2 delivery
occurred via the increase in perfusion pressure, no vasodilation occurred (no significant increase
in conductance) as we have previously observed (4; 82). In contrast, after prazosin much larger
increases coronary blood flow occurred due to the combined effect of substantial vasodilation
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coupled with increased perfusion pressure and the increases in PRSW were much greater.
Collectively, we interpret these data as indicating that during metaboreflex activation, the
increases in sympathetic activity prevents coronary vasodilation and therefore restrains
increases in coronary blood flow to only that which occurs via increases in perfusion pressure
(4; 82). 1 adrenergic blockade revealed substantial coronary vasodilation during metaboreflex
activation which now coupled with the rise in perfusion pressure provided for much greater
increases in coronary blood flow. The increased blood flow and O2 delivery thereby elicited a
greater increase in ventricular contractility. Gwirtz and colleagues (36; 37; 52) showed that
blockade of coronary 1 adrenergic receptors increased coronary blood flow during moderate
exercise in dogs. This was also accompanied by higher myocardial O2 consumption and
regional ventricular dynamics (increased maximal velocity of segment shortening). Thus the
rise in sympathetic activity that normally occurs with moderate exercise likely functionally
restrains coronary vasodilation and ventricular function. One possible beneficial effect of this
vasoconstriction may be to preserve endocardial blood flow (43), inasmuch as the epicardium is
vasoconstricted to a greater extent than the endocardium, which would act to redistribute
coronary blood flow towards the inner layers of the ventricle. This greater vasodilation with 1
blockade could be revealing both metabolic vasodilation as well as  mediated feed-forward
vasodilation (34).
Muscle metaboreflex activation either during exercise or during post-exercise circulatory
occlusion causes marked increases in cardiac work, yet, little if any coronary vasodilation is
observed (4; 72; 82). Similar results are observed with strong static muscle contractions (61;
73). Previous studies from our laboratory have shown that metaboreflex activation during submaximal dynamic exercise caused no coronary vasodilation despite marked increases in heart
rate and ventricular contractility.

Cardiac output increased substantially and was pumped
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against a much higher afterload, yet all of the increase in coronary blood flow occurred via
increases in perfusion pressure rather than vasodilation (4). These results indicated that a
“push-pull” situation exists between the vasodilatory drives and the vasoconstrictor effects of
the increased sympathetic activity.

If the increase in cardiac work during metaboreflex

activation is reduced, actual coronary vasoconstriction is seen (4). Similarly, during maximal
exercise when heart rate and cardiac output are already at maximal levels and little further
steady-state increase in ventricular work occurs, metaboreflex activation causes coronary
vasoconstriction (4). Finally, in heart failure little or no metaboreflex increases in contractility
occur and the reflex increase in cardiac sympathetic activity causes frank coronary
vasoconstriction (3). To what extent this actual coronary vasoconstriction contributes to the
inability to raise ventricular contractility and cardiac output during metaboreflex activation in
heart failure is unknown.
Baroreflex vs. Metaboreflex
We used systemic α adrenergic blockade rather than injection into a coronary artery
because we wanted to assess the effects on total ventricular function rather than only an
individual ventricular segment which is more susceptible to changes in loading conditions (48;
58). After prazosin, MAP was lower due to the peripheral vasodilation which raises the
question as to what extent the enhanced increases in CO and ventricular contractility reflect
baroreflex responses. We feel this is unlikely for several reasons. Heyndrickx et al. (42)
previously showed that during exercise after systemic infusion of prazosin, whereas arterial
plasma levels of norepinephrine were increased, there was no increase in norepinephrine release
at the heart itself despite a large decrease in MAP. After prazosin in the present study, neither
at rest, nor during mild exercise were cardiac output or preload recruitable stroke work higher
than control levels (a small rise in dP/dt did occur which may reflect changes in preload and/or
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afterload, (48)). In addition coronary blood flow was unchanged; the small increase in coronary
conductance was offset by the small reduction in perfusion pressure. Thus, whereas MAP was
lower after α1 blockade which would elicit a baroreflex response (tachycardia), this resulted in
no significant increase in cardiac output or ventricular contractility as stroke volume fell with
the rise in heart rate. The fall in stroke volume with this rise in rate is very similar to that
observed with merely increasing pacing rate within this range which also elicits little if any
increase in CO (107). We have recently shown that this increase in rate by itself would have
very little direct effects on ventricular contractility (Treppe effect) in this model (15). In
contrast, a similar tachycardia induced by activation of the muscle metaboreflex causes large
increases in CO and ventricular contractility (95). Further, in both dogs (17) and humans (85),
carotid baroreceptor unloading during exercise causes little steady state increase in CO. The
baroreflex pressor response is mediated via increases in peripheral resistance (17; 85). After 1
adrenergic blockade, only when the metaboreflex was activated did cardiac output, ventricular
contractility, coronary vascular conductance and coronary blood flow all rise above levels
observed during the control experiments whereas the difference in MAP was similar to that at
rest and during mild exercise. We feel this is compelling evidence that the response was indeed
metaboreflex in nature as the major effects on CO and PRSW were only observed when the
metaboreflex was activated and not at rest or during exercise when pressure was similarly
lowered with 1 blockade.
The arterial baroreflex normally acts to buffer the metaboreflex (51). Whether the rise
in sympathetic activity which occurred with metaboreflex activation was greater after 1
blockade because MAP did not rise to the same extent cannot be discounted. However, we
recently showed that after removal of the buffering effects of the arterial baroreflex (sino-aortic
arterial baroreflex denervation), the much larger metaboreflex pressor response occurs via
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increased peripheral vasoconstriction. Indeed, the rise in CO is if anything slightly smaller after
baroreceptor denervation (50). Further, the higher slope of the relationship between coronary
conductance and cardiac power indicates that greater vasodilation occurs with 1 blockade as
power increases during metaboreflex activation. Thus, even at the same cardiac power, larger
coronary vasodilation occurs. Similarly, the overlap of the data relating PRSW to coronary
blood flow indicates that if the rise in coronary blood flow was the same after 1 blockade, then
ventricular contractility would have risen to the same extent.
Limitations:
Cardiac power is a relatively novel measure of cardiac function (28; 67), and in the
present study was used as an index of myocardial oxygen consumption. Previous studies
performed in humans used cardiac power calculated as product of cardiac output and mean
arterial pressure. Khouri et al. (49) previously used a similar calculation and they referred to it
as cardiac work or left ventricular work. However, power is work performed over time so we
feel cardiac power is the correct term, especially so as we calculated cardiac power as stroke
work (work/beat) times heart rate (beats/minute), therefore resulting in work/minute. Khouri et
al. (49) showed an excellent correlation between this and myocardial O2 consumption. Cardiac
power has been shown to be a strong indicator of prognosis in chronic heart failure (108), and a
strong predictor of mortality due to cardiogenic shock (28). Most recently there has been
evidence to suggest that cardiac power can be a very useful prognostic tool in across a broad
spectrum of acute cardiac diseases (67).
PRSW has been shown to be a very robust index of cardiac contractility (47). However
our technique used to estimate left ventricular volume has limitations. On average, the left
ventricular volume values calculated from the sonomicrometry crystals underestimated the SV
obtained by integrating the signal from cardiac output flow probe placed on the ascending aorta.
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We showed previously that this underestimation is highly linear within each animal (95).
Similarly low SV values for dogs of this size were reported by others using sonomicrometery
(58; 94; 95).

To our knowledge, our studies are the only in which SV was measured

simultaneously via these two techniques. This discrepancy between the SV values calculated
using sonomicrometry vs. CO likely occurred due to the number of crystals used and their
placement on the left ventricle. In our study, only two pairs of crystals were used, in order to
limit any damage made to the myocardium. In two animals we simultaneously measured left
ventricular volumes via sonomicrometry as well as echocardiography while also monitoring CO
via the implanted blood flow transducer. As we suspected, values for end diastolic volume for
echocardiography and sonomicrometry were very similar whereas the values for stroke volume
were very similar between echocardiography and that calculated from the ascending aortic flow
probe. Therefore, we believe that the error in the sonomicrometry value for stroke volume
resides in over estimating end systolic volume. Therefore, for the volume data shown in figure
2.2 we used the end diastolic volume obtained from sonomicrometry and stroke volume from
the aortic flow signal. These calculations yield reasonable estimates of other parameters such as
ejection fraction.
In the present study, systemic vascular conductance to all areas except the hindlimbs
(NIVC) also increased with metaboreflex activation after α1 receptor blockade. In a limited
number of previous experiments, this systemic vasodilation was abolished by propranolol (82).
NIVC reflects mostly skeletal muscle (51). Thus, this vasodilation likely is within skeletal
muscle and may occur via epinephrine release from the adrenal glands (53). This may explain
why with metaboreflex activation vasoconstriction is seen in select vascular beds, but no global
change in NIVC is observed (7; 8; 39; 70; 71). It is possible that a portion of the coronary
vasodilation seen after 1 adrenergic blockade was due to 2 adrenergic receptor stimulation via
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an increase in circulating epinephrine in addition to the marked increase in ventricular work(41).
In summary, muscle metaboreflex activation increases sympathetic tone to 1 adrenergic
receptors, and functionally restricts coronary vasodilation. This impedes blood flow to the
myocardium and limits the increase in left ventricular performance. This likely limits the
ability of the reflex to raise cardiac output and therefore restore blood flow to the ischemic
muscles.
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CHAPTER 3
Muscle Metaboreflex-Induced Coronary Vasoconstriction Limits Ventricular
Contractility during Dynamic Exercise in Heart Failure
Abstract
Muscle metaboreflex activation (MMA) during dynamic exercise increases cardiac work
and O2 demand via increases in heart rate, ventricular contractility and afterload. This increase
in cardiac work should lead to metabolic coronary vasodilation.

However, no change in

coronary vascular conductance is seen, indicating that the increased sympathetic activity which
increased contractility also caused vasoconstriction. In heart failure, cardiac output does not
increase with MMA presumably due to impaired left ventricular contractility, and large
decreases in coronary vascular conductance are observed. We tested whether this coronary
vasoconstriction could explain in part, the reduced ability to increase cardiac performance
during MMA. In conscious, chronically instrumented dogs after pacing induced heart failure,
MMA responses during mild exercise were observed before and after 1 adrenergic blockade
(prazosin 50-100g/kg). During MMA, the increases in coronary blood flow, coronary vascular
conductance, cardiac output, and +dP/dtmax were significantly greater after 1 adrenergic
blockade. We conclude that during heart failure the coronary vasoconstriction limits the ability
of muscle metaboreflex to increase left ventricular contractility.
Introduction
During exercise, metabolite sensitive afferent neurons within the skeletal muscle may be
stimulated and evoke a reflex increase in sympathetic nerve activity to the heart and vasculature,
known as the muscle metaboreflex (3; 8; 39; 62; 70; 87; 98-101; 106). In normal subjects
during submaximal exercise the metaboreflex elicits an increase in blood pressure mainly via a
marked increase in cardiac output (CO) (2; 6; 8; 22; 39; 98; 109). This increase in flow serves
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to partially restore blood flow and oxygen delivery to the ischemic muscle (80; 83).
However, in heart failure, this reflex increase in blood pressure occurs mainly due to
peripheral vasoconstriction, as little or no increase in CO occurs (3; 39; 81; 93). Despite
tachycardia, the metaboreflex does not increase CO, due to a marked drop in stroke volume
(SV) (21; 39; 93). This is likely due to an inability to increase left ventricular contractility
which is an important component of the cardiac response allowing SV to be maintained or even
increased slightly in the face of increased afterload (79; 81; 95). The inability to increase
contractility in heart failure can be attributed to several factors. Structurally, the ventricle is
enlarged with no increase in wall thickness, leading to elongated myocytes (reviewed in 29; 35),
disorganization of myofilaments (96; 102; 103), transverse tubule and mitochondrial swelling,
as well as mitochondrial rupture and consequently decreased mitochondrial density (96; 103).
Another factor that may play a role in the reduced cardiac function during exercise and
metaboreflex activation is a limited oxygen supply to the myocardium. In humans (23; 74) and
animals (76), heart failure has been shown to increase myocardial oxygen consumption.
Coronary blood flow also increases during heart failure (74). However coronary flow reserve is
impaired during heart failure, indicating a possible restraint of coronary blood flow during high
oxygen demand situations such as exercise.

This restraint may occur via sympathetic

vasoconstriction of the coronary vasculature. Even in normal subjects during exercise the left
ventricle is functionally vasoconstricted inasmuch as coronary vasodilation increases with 
adrenergic blockade (20; 37; 43) and with the increase in blood flow, significant increases in
left ventricular contractility occur (20; 37).
In normal subjects, muscle metaboreflex activation markedly increases ventricular work,
and while coronary blood flow rises with the substantial increase in arterial pressure, little or no
coronary vasodilation is seen (4; 20; 72; 82). With metaboreflex activation in heart failure,
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frank coronary vasoconstriction occurs (3).

To what extent this functional metaboreflex-

induced coronary vasoconstriction in heart failure limits the ability to improve ventricular
function and therefore ultimately limits the ability to increase cardiac output and improve
oxygen delivery to the active muscle is unknown.
Methods
All of the methods and procedures were reviewed and approved by the Wayne State
University Institutional Animal Care and Use Committee. The experiments were conducted on
mongrel dogs (N=7), weighing 22.7 (+/- 2.02) kg. The dogs were selected for their willingness
to walk/run on a motor-driven treadmill. There was no intended selection was made for gender,
however by random all animals were female. No dogs were in the proestrus phase of the
menstrual cycle during the experiments. Previously this laboratory has shown that gender has
little or no effect on metaboreflex responses in dogs (55).
The medications and surgical preparations used have been described in detail previously
(95), (3; 4; 84). Briefly, a 20mm flow transducer was placed around the aortic root to measure
cardiac output. Hydraulic vascular occluders were placed on the superior and inferior vena
cavae to manipulate preload. Two pairs of sonomicrometry crystals were implanted in the
endocardium of the left ventricle on the short axis and long axis to estimate ventricular volume.
A catheter was placed in the left ventricle for left ventricular pressure and its telemeter-pressure
transducer was implanted subcutaneously.

A 3 mm flow transducer was placed on the

circumflex artery to assess coronary blood flow (CBF). Three ventricular pacing wires (0Flexon) were sutured to the free wall of the right ventricle for subsequent ventricular pacing to
induce HF. Arterial and central venous catheters were placed to measure systemic blood
pressures. In the retroperitoneal region, a vascular occluder was placed about the terminal aorta.
Just proximal to this occluder, a 10mm flow transducer was placed about the aorta to measure
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hind-limb blood flow (HLBF).
Experimental Protocol
Each dog was directed to stand on the treadmill for 10-15 minutes while all equipment
was connected and adequacy of the signals verified. All data were recorded on digital recording
systems (Windaq, and Sonometrics).
We obtained 1 minute of steady-state resting data with the dog standing on the treadmill.
Steady-state data and data during transient vena caval occlusions (for variably loaded pressurevolume (PV) loops) were recorded during the conditions of: rest, mild exercise (3.2 km/h), and
mild exercise with muscle metaborelex activation.

The reflex was activated by partially

inflating the vascular occluder on the terminal aorta to reduce hindlimb blood flow to
approximately 50% of the normal value during mild exercise. The experiments were performed
with and without -blockade (prazosin; 20-50 g/kg, i.v. 30 minutes prior to exercise). In each
experiment, the dose of prazosin was sufficient to abolish any pressor response to 4 μg/kg of
phenylephrine for the duration of the experiment. After completion of the control and blockade experiments, congestive heart failure was induced via rapid ventricular pacing. This
technique has been widely accepted to create chronic model of left ventricular failure (39; 40).
Briefly, the right ventricular pacing electrodes were connected to a pacemaker set at 200 - 220
beats/minute for ~ 30 days. When signs of congestive heart failure appear, such as: anorexia,
decreased cardiac output, stroke volume reduction > 30%, increased left ventricular end
diastolic pressure, and increased heart rate; the experiments were repeated. The pacemaker was
disconnected during the experiments.
Data Analysis
We calculated left ventricular volume using a modified ellipsoid equation. [LVV =
(π/6)x(SA)2x(LA)]. Where LVV is the left ventricle volume, SA (short axis) represents the
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distance between the anterior and posterior crystals, and LA (long axis) represents the distance
between the crystals placed on the base and apex of the left ventricle. The pressure-volume
loops were plotted for each condition. Preload recruitable stroke work (PRSW), and +/- dP/dt
were calculated. PRSW is the slope of the relationship between stroke work and the LVV. An
increased slope reflects an increased contractility and vice-versa (30; 47; 60). Cardiac power
was calculated as the product of stroke work and heart rate. The integral of the cardiac output
wave was calculated to give stroke volume. Left ventricular volume data were corrected using
the end diastolic volume obtained from sonomicrometry and stroke volume from the aortic flow
signal, as discussed in a previous study (20). Coronary vascular conductance (CVC) was
calculated as CBF/(MAP-CVP). Systemic vascular conductance to all non-ischemic areas (e.g.
all areas except the hindlimbs) is termed non-ischemic vascular conductance (NIVC) and was
calculated as (CO-HLBF)/ (MAP-CVP). A repeated measures factorial ANOVA, was used for
the main effects analyses, and a pair-wise comparison was used for post-hoc analyses using the
Test for Simple Effects. Statistical significance was defined as P < 0.05.
Results
The expected hemodynamic changes due to heart failure, such as attenuated arterial
pressure, stroke volume, cardiac output, and elevated heart rate were observed (Table 3.1)..

Table 3.1. Haemodynamics (MAP, HR, SV, CO) observed in normal animals and after
induction of heart failure.
MAP (mmHg)
HR (bpm)
SV (mL)
CO (L/min)

Normal

Heart Failure

97 ± 4.4
88 ± 5.7
40 ± 3.0
3.5 ± 0.2

76 ± 1.4 †
117 ± 5.2 †
25 ± 2.1 †
2.8 ± 0.2 †

Hemodynamic parameters during normal and heart failure
conditions, † signifies a difference between the two conditions
(P < 0.05).
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In heart failure, prazosin caused a small, but significant increase in HLBF over the heart
failure values at rest and during exercise without prazosin. In all conditions: control, control 
blockade, heart failure, and heart failure  blockade, HLBF rose from rest to mild exercise.
HLBF was reduced to the same values for activation of the muscle metaboreflex in all
conditions (Table 3.2).
Figure 3.1 shows the mean steady state values of MAP, HR, left ventricular end diastolic
and end systolic volumes, CO, and NIVC, at rest, mild exercise, and during exercise with
metaboreflex activation in control and after 1 blockade (panel A). In control there was no
change in MAP from rest to mild exercise, however SV, CO, and NIVC were increased.
Imposed reductions in HLBF caused muscle metaboreflex-induced increases in MAP, SV and
CO.

No significant change in NIVC occurred with metaboreflex activation.

At rest, 1

blockade caused a significant decrease in MAP, marked tachycardia and reduced SV, due to a
reduced end diastolic volume.

Responses to mild exercise were similar to control.

Metaboreflex activation caused a significant though lesser increase in MAP, and a significant
increase in SV. End diastolic volume was still reduced compared to control, however end
systolic volume was also reduced, resulting with a comparable SV between control and 1
blockade. A greater reflex increase in CO as compared to control and a significant increase in
NIVC occurred. HR was significantly different across workloads, and significantly different
between conditions (control vs. 1 blockade) but no significant interaction, so a pairwise
comparison could not be calculated.
After induction of heart failure (panel B) there was no change in MAP or SV from rest
to mild exercise, however HR, CO, and NIVC were increased. Imposed reductions in HLBF
caused muscle metaboreflex-induced increases in MAP and HR, but a decrease in SV and
NIVC. There was no change in CO with metaboreflex activation. Thus, the mechanisms of the
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reflex shifted from increased CO in the normal animal to increased peripheral vasoconstriction
in HF. At rest, 1 blockade did not affect MAP, or HR. SV increased, due to an increased end
diastolic volume. During mild exercise LV end systolic volume decreased, which resulted in an
increased stroke volume. CO and NIVC also increased greater than observed prior to 1
blockade.

Metaboreflex activation caused a similar increase in MAP as that without 1

blockade, however the mechanisms of the pressor response were markedly different. End
systolic volume decreased, resulting in an increase in SV with 1 blockade in HF. End diastolic
volume was not significantly different across workloads, or between conditions (control vs. 1
blockade), so a pairwise comparison could not be calculated. The rise in SV coupled with the
tachycardia now caused a significant increase in CO. Rather than a decrease in NIVC, a small
increase was observed as was also seen in the normal animal during meatboreflex activation
after 1 blockade. Thus, after 1 blockade in HF the metaboreflex pressor response returned to
a cardiac output based response as seen prior to induction of HF.
Figure 3.2 shows left ventricular hemodynamic and performance responses to mild
exercise and metaboreflex activation in control and after 1 blockade (panel A) as well as heart
failure, and heart failure with 1 blockade (panel B). In control there were significant increases
from rest to mild exercise in CBF, CVC, dP/dtmax, and PRSW.

Metaboreflex activation

increased coronary blood flow and left ventricular contractility, however no vasodilation
occurred in the coronary circulation as there was no significant increase in CVC, thus all of the
increase in CBF was due to the increase in perfusion pressure. Under 1 blockade there was
also a significant increase in all parameters from rest to mild exercise, which were statistically
greater in CVC and dP/dtmax compared to control. After 1 blockade, activation of the muscle
metaboreflex now elicited significantly greater increases in CBF. Although the rise in perfusion
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pressure was smaller, substantial coronary vasodilation occurred. Metaboreflex activation in
this setting caused significantly greater increases in both indices of myocardial contractility.
CBF and CVC were higher at rest in heart failure compared to control, while dP/dtmax
and PRSW were reduced.

CBF, CVC, and dP/dtmax all increased from rest to mild exercise.

Metaboreflex activation increased coronary blood flow and dP/dtmax, however vasoconstriction
occurred in the coronary circulation as CVC decreased significantly. Under 1 blockade there
was also a significant increase in all illustrated parameters from rest to mild exercise, which
were statistically greater in CBF, CVC and dP/dtmax compared to control. After 1 blockade,
activation of the muscle metaboreflex now elicited significantly greater increases in CBF, CVC
and dP/dtmax.

In this case PRSW was assessed in a smaller sample (N=3).

PRSW was

significantly different across workloads, and significantly different between conditions (control
vs. 1 blockade) however no significant interaction occurred, so a pairwise comparison could
not be calculated.
Figure 3.3 illustrates the relationship between coronary vascular conductance and
cardiac power following heart failure (A), as well as the changes in CVC with respect to the
changes in cardiac power (CVC:CP ratio), from rest to mild exercise, and from mild exercise
to MMA in control (B) and after the induction of HF (C). From rest to mild exercise there is a
positive relationship both with and without  blockade. That is, as cardiac power increased,
coronary vasodilation occurred and this relationship was unaffected by  blockade. With
metaboreflex activation whereas cardiac power increased, little vasodilation occurred and this
ratio fell.

With  blockade, increases in both cardiac power and CVC occurred with

metaboreflex activation and this ratio increased significantly.

After the induction of HF,

whereas with the transition from rest to exercise both CVC and cardiac power rose (therefore
positive value for this ratio), with metaboreflex activation since CVC decreased despite a very
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small increased cardiac power this ratio became markedly negative.  blockade reversed this
ratio back to a positive value as now vasodilation did occur with increased cardiac power.
Figure 3.4 shows the relationship between dP/dtmax and CBF (panel A, R2 = 0.98) and
between PRSW and CBF (panel B, R2 = 0.97, N=3). In both panels all 6 points in control (with
and without  blockade) were combined into one regression, as were all six points in heart
failure. After  blockade, greater increases in CBF occurred with metaboreflex activation
which also elicited substantially greater increases in ventricular contractility. A similar linear
response was observed in heart failure; however the slope of the relationship is much lower.

Table 3.2. Hind limb blood flow (L/min ± SE) at rest, during mild exercise, and metaboreflex
activation, in control and heart failure conditions, before and after 1 adrenergic blockade.
Control
α1-blockade

Rest

Ex.

Ex.+MMA

0.58±0.05
0.61±0.06

1.00±0.09 †
1.07±0.09 †

0.52±0.04
0.55±0.04

0.46±0.05
0.86±0.11 †
0.51±0.06
Heart Failure
0.57±0.07 *
1.16±0.119 *†
0.51±0.06
α1-blockade
Levels of hindlimb blood flow before and after  adrenergic blockade, shown with control, heart failure &
their corresponding 1 blockade conditions. During Ex+MMA, hindlimb blood flow was mechanically
reduced to the same values in both conditions. * signifies a significant pairwise comparison (P < 0.05). †
signifies a significant increase from rest to mild exercise (P < 0.05)).
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A

B

Figure 3.1: Hemodynamic
responses: Mean arterial
pressure (MAP), heart rate
(HR), Left Ventricular
Volumes
(Left
VVs),
cardiac output (CO), and
non-ischemic
vascular
conductance
(NIVC);
during rest, mild exercise
(Ex), and mild exercise
with MMA (Ex+MMA); in
control (Panel A) and heart
failure (panel B) (black
bars) and the corresponding
1 blockade conditions
(striped
bars).
All
parameters
showed
significance
across
workload settings, as well
as significance between
control
and
prazosin
conditions (P < 0.05). All
parameters had a significant
interaction between the two
independent variables, with
the exception of hear rate in
control and control after 1
blockade.
*(column)
signifies
a
significant
pairwise
comparison
(P<0.05).
†signifies
a
significant increase from
the previous workload.
♣signifies a significant
pairwise comparison in left
ventricle stroke volume (P
< 0.05). ‡ signifies a
significant increase in LV
end diastolic volume while
# indicates a significant
increase in stoke volume
from the previous workload
(P < 0.05). *(bracket)
indicates a significance between LV end systolic volume across workloads but not between
control and 1 blockade conditions.
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3.2:
Left
ventricular
hemodynamic
and
function
responses:
Coronary blood flow
(CBF),
coronary
vascular conductance
(CVC), maximal rate of
left ventricular pressure
change (dP/dtmax), and
preload
recruitable
stroke work (PRSW);
during
rest,
mild
exercise (Ex), and mild
exercise with MMA
(Ex+MMA); in control
(Panel A) and heart
failure (panel B) (black
bars)
and
the
corresponding
1
blockade
conditions
(striped bars).
All
parameters showed a
significance
across
workload settings, as
well as significance
between control and
prazosin conditions (P
< 0.05). All parameters
had
a
significant
interaction between the
two
independent
variables, with the
exception of PRSW in
panel B, (N=3). An *
above a specific setting
signifies a significant
pairwise comparison (P
< 0.05). A † above a
column signifies a
significant
increase
from the previous
workload (P < 0.05).
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Figure 3.3:
Coronary vascular
conductance (CVC) plotted as a function
of cardiac power (A). Ratio between
change in coronary vascular conductance
(CVC) change in cardiac power (CP)
in control (B) and heart failure (C). The
black bars represent control while the
striped bars represent the corresponding
1 blockade. Both are compared across
rest to mild exercise (Rest to Ex.) and
mild exercise to muscle metaboreflex
activation (Ex. to MMA). An * above a
specific setting signifies a significant
pairwise comparison (P < 0.05). A †
above a column signifies a significant
increase from the previous setting (P <
0.05).
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Figure 3.4: Contractility indicated by dP/dtmax (A) and preload recruitable stroke work
(PRSW) (B) with respect to coronary blood flow (CBF). As no significant difference between
control and 1 blockade was found (P > 0.05), a single relationship is represented by a single
line. The averaged values in heart failure are represented with black triangles (▲) while
averaged values during 1 blockade are shown as open triangles (∆). In panels B and C, control
and heart failure are combined with their corresponding 1 blockade conditions. The averaged
values in control are represented with black circles (●) and control with 1 blockade with open
circles (○), while averaged values during heart failure are shown with triangles as previously
described.
Discussion
Our major finding is that the inability to raise ventricular contractility during
metaboreflex activation in subjects with heart failure is, in part, due to coronary
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vasoconstriction and the resultant limitation in the ability to raise coronary blood flow and O2
delivery. Thus, ventricular dysfunction during exercise in heart failure stems both from the
impaired contractile function as well as restrained ability to raise coronary blood flow due to 
mediated coronary vasoconstriction.
Previously we have shown in normal subjects that the muscle metabreflex-restrained
coronary vasodilation functionally limited left ventricular contractility (20).

Even during

moderate to heavy exercise in normal subjects there is a constant push/pull situation between
the vasodilatory stimuli of metabolic as well as possible β2-mediated feed forward vasodilation
(34), vs. the vasoconstricting effects of coronary vascular  adrenergic receptor stimulation
(37; 38; 72; 82). In heart failure, sympathetic activity is chronically elevated (25; 56) as are
circulating catecholamine levels (25; 40). During muscle metaboreflex activation in heart
failure, sympathetic activity is markedly increased (39). This increased sympathetic drive
coupled with a limited ability to increase metabolic rate likely shifts the push/pull balance
towards vasoconstriction, thereby limiting the increase in coronary blood flow and therefore
oxygen supply to the heart. (3; 20). This reduced ability to increase O2 delivery contributes
significantly to the inability to raise ventricular contractility. The suppressed increases in left
ventricular contractility likely limits the ability to increase cardiac output and therefore impedes
the main function of the reflex which is to restore blood flow to ischemic working skeletal
muscle.
Effect of heart failure
Several structural and functional impairments occur during heart failure including
ventricular remodeling as well as extensive cellular damage. The reduced cardiac function
results from a myriad of complications including abnormal myosin cross-bridge activity (102;
103), prolonged calcium transients due to dysfunctional calcium channels on the sarcoplasmic
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reticulum (35), reduced myocyte 1 adrenergic receptor density as well as a greatly reduced
adenylate cyclase activity, indicating that myocardial 1 receptor function is also attenuated (13).
This reduced number and function of myocardial 1 receptors helps explain the reduced calcium
handling capacity as sympathetic activity is increased during heart failure (25; 56).

The

ventricular structural remodeling further attenuates cardiac function (46; 102; 103).
In the present study we hypothesized that limited oxygen delivery to the myocardium
may be another important factor contributing to the reduced cardiac performance during
metaboreflex activation in heart failure. We showed that muscle metaboreflex activation during
heart failure elicited coronary vasoconstriction, which in turn suppressed increases in blood
flow to the myocardium which would have occurred with the pressor response. With the
coronary vasodilation and larger increases in coronary blood flow after a receptor blockade,
increases in contractility and cardiac power were seen with metaboreflex activation in heart
failure.

Canetti et al showed that the maximal capacity for coronary arteries to dilate is

impaired during heart failure (14), indicating a possible restraint of coronary blood flow during
high oxygen demand situations such as exercise and metaboreflex activation.
Coronary Hemodynamics and Ventricular performance
We showed that the CVC-Cardiac Power relationship is normally markedly suppressed
with heart failure compared to normal subjects (Figure 4). In a recent study from this laboratory
(20) we used an analysis based on that done by Huang and Feigl (43). This relates the vascular
response as a function of the O2 consumption. The vascular response may be blood flow if
pressure is constant, but since pressure changes we used vascular conductance since changes in
pressure will change flow directly independent of any change in the vasculature. We used
cardiac power (stroke work times heart rate) as an index of the steady-state O2 demands of the
heart (28; 49; 67). We showed that in the normal heart there is a linear relationship between
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CVC and Cardiac Power and that the slope of this releationship is shifted upwards after 1
receptor blockade. This indicates that after blockade of the coronary vasoconstrictor effects of
the rise in cardiac sympathetic activity during metaboreflex activation, a given increase in
myocardial workload would give rise to a greater vasodilation. However this linear model is
lost in heart failure. Metaboreflex activation caused trivial increases in cardiac power and frank
coronary vasoconstriction occurred. Therefore, to analyze this relationship, the ratio of CVC
to CP was calculated separately for the transitions from rest to exercise, and from exercise to
metaboreflex activation. With metaboreflex activation in normal subjects, this ratio is reduced
from that with the transition from rest to mild exercise; however during metaboreflex activation
after 1 receptor blockade a higher ratio was observed. This indicates that a larger vasodilation
will occur for a given increase in cardiac power after removal of the vasoconstricting effects of
the rise in cardiac sympathetic activity. In contrast, after induction of heart failure, with
metaboreflex activation this ratio actually becomes quite negative meaning that coronary
vasoconstriction occurred with the increase in ventricular work. This ratio was reversed to a
positive value with 1 blockade. This marked change in the vasodilation/function relationship
with 1 blockade underscores the severe consequences of coronary vasoconstriction in heart
failure.
In both normal subjects and after induction of heart failure, there was a single linear
relationship whether with or without 1 blockade conditions, heart failure substantially lowered
the slope of this relationship. Blockade of coronary vasoconstriction extended this relationship
to higher levels of flow and contractility. The lower slope seen in heart failure shows that
whereas ventricular function is dependent on flow, this dependency is less than in the normal
heart. However, in heart failure ventricular function is already so depressed that relatively small
increases in contractile strength may make significant differences in overall cardiovascular
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function.
In the present study prazosin was used as an 1 – adrenergic blocker. The clinical
efficacy of systemic 1 – adrenergic blockade to improve performance of the failing heart has
been tested clinically. Short-term results showed that prazosin therapy provides favorable
hemodynamic responses (5; 9; 16; 18; 26; 31; 64; 68; 92), such as: reduced pulmonary venous
congestion, improved end diastolic and systolic volumes, increased coronary flow, cardiac
output, and improved NYHA functional class. However, studies found that such responses
were attenuated in the long-term (18; 26) and that there was no improvement in mortality (16).
Another concern with the long-term clinical use of prazosin is the possible attenuation of
ventricular preload below that of optimal filling pressure (9). The lack of efficacy of prazosin
as a treatment for heart failure may indicate there are still other factors involved in heart failure
and also be a compensatory affect of the body. The systemic effects of prazosin may also
complicate its clinical usefulness. If alpha receptor blockade could be targeted to the coronary
vasculature, a different outcome of treatment may be possible.
Limitations
In our previous study (20) a concern was discussed regarding the possibility of a larger
increase in cardiac output induced by a baroreflex response to the reduced arterial pressure
during 1 blockade. In this study however 1 blockade did not have a significant influence on
arterial pressure making any baroreflex effect similar with or without 1 blockade.
We observed systemic vasodilation (with exception of the hindlimbs) with muscle
metaboreflex after 1 blockade. A large portion of this change likely occurs in skeletal muscle
(51). In previous experiments from this laboratory, after infusion of propranolol this systemic
vasodilation no longer occurred (82), indicating a likely 2 mediated adrenergic vasodilation. It
is possible that some of the coronary vasodilation observed is also 2 mediated vasodilation.
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However any 2 vasodilation would likely be modest (33).
Due to difficulties in attaining PRSW during heart failure, we were limited to a small
sample size (N=3). However a clear trend is visible to supplement the results observed with
dP/dtmax. Although, dP/dtmax is considered sensitive to changes in loading conditions (48; 60), it
is still considered a widely used index of contractility.
In summary, muscle metaboreflex activation during heart failure further increases
sympathetic tone to 1 adrenergic receptors and functionally restricts coronary vasodilation.
This limits increases in blood flow to the myocardium which thereby limits the increase in left
ventricular performance. This is likely one factor limiting the ability of the reflex to raise
cardiac output during heart failure. Thus, the inability to effectively raise cardiac output during
metaboreflex activation in heart failure is not only due to the ventricular dysfunction, but also is
in part a result of coronary vasoconstriction.
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Muscle metaboreflex activation during dynamic exercise induces a substantial increase
in cardiac work and oxygen demand via a significant increase in heart rate, ventricular
contractility and afterload. This increase in cardiac work should cause coronary metabolic
vasodilation. However, little if any coronary vasodilation is observed due to concomitant
sympathetically induced coronary vasoconstriction. In heart failure, cardiac output does not
increase with MMA presumably due to impaired left ventricular contractility, and large
decreases in coronary vascular conductance are observed. The purpose of this dissertation is to
determine whether the muscle metaboreflex-induced restraint of coronary vasodilation
functionally limits coronary blood flow and suppresses increases in left ventricular (LV)
contractility in normal dogs and whether this coronary vasoconstriction could explain in part,
the reduced ability to increase cardiac performance during heart failure conditions. We used
chronically instrumented dogs (n=9, control and n=7, heart failure) and measured arterial
pressure (MAP), cardiac output (CO), circumflex blood flow (CBF), and calculated coronary
vascular conductance (CVC), maximal derivative of ventricular pressure (dp/dt), and preload
recruitable stroke work (PRSW) at rest and during mild exercise (2mph) before and during
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activation of the muscle metaboreflex.

Experiments were repeated after systemic alpha-1

adrenergic blockade (prazosin 50-100g/kg).

In control studies during 1 blockade we

observed significantly greater increases in CVC, CBF and PRSW, as well as CO and dP/dtmax,
with metaboreflex activation vs. those seen without 1 blockade. In heart failure experiments
during MMA, the increases in CBF, CVC, CO, and +dP/dtmax were significantly greater after 1
adrenergic blockade. We conclude that the coronary vasoconstriction elicited by MMA limits
the ability of muscle metaboreflex to increase left ventricular contractility in normal and heart
failure conditions.
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